I'm really interested to know what this undisclosed product is -...

I'm really interested to know what this undisclosed product is - it was submitted to FDA in FY21 (see screenshot). I'm hoping this is a golden nugget i.e. difficult to replicate the drug and no competitors.

I still believe in the strategy. I do think they need to review their board composition and the salary levels of senior management e.g. why should the CFO get paid so much? Its not hard to be the CFO of a 35m market cap business. I work at an overseas investment Bank and the CFO of our division that generates over 3bn in revenues, is probably only getting slightly more that Acrux's CFO

What are all the board members actually doing? I hope they are adding some sort of value.